Directorate Change

Press Release: 23 November 2010

            Reckitt Benckiser appoints new Chief Financial Officer             

Reckitt Benckiser Group PLC (RB) announces it is appointing Liz Doherty as
chief financial officer (CFO). Liz, who is British, was CFO at Brambles
Industries PLC for 2 years. A top 25 company on the Australia stock market, the
supply chain and information management solutions provider has a market cap of
Aus$9.7bn and operates across 45 countries. Prior to Brambles, Liz was the
number 2 in the finance function at Tesco PLC where she was group international
finance director with additional responsibility for corporate accounts, group
tax and treasury. She was 7 years at Tesco PLC, having joined from Unilever
PLC, where she had a 22-year career. She has 14 years international experience
having worked in Australia, Spain, the Netherlands and Thailand.

Liz has been a non-executive director of SABMiller PLC since 2006, a role from
which she will be standing down ahead of joining RB.

Commenting on her appointment, RB chief executive, Bart Becht, says, "I am
delighted to welcome Liz. She has excellent international, consumer and listed
company experience. In addition she is a great cultural fit for RB showing the
focus and drive that RB looks for."Liz Doherty will join RB in January 2011 and
have a period of handover with Colin Day the outgoing CFO.

                                   - ENDS -                                    

Notes to Editors

Reckitt Benckiser (RB) is a world leader in household, health and personal
care.

It is a FTSE top 25 company and since 2000 net revenues have doubled and the
market cap has quadrupled. Today it is the global No 1 or No 2 in the majority
of its fast-growing categories, driven by an exceptional rate of innovation -
typically about 35% of net revenue comes from innovations launched in the prior
3 years. It has a strong portfolio led by 19 global powerbrands which are:
Finish, Lysol, Dettol, Vanish, Woolite, Durex, Calgon, Airwick, Harpic, Bang,
Mortein, Veet, Nurofen, Clearasil, Strepsils Gaviscon, Mucinex, Scholl and
French's.

RB people are at the heart of the company's success. They have an intense drive
for progress and action and a desire to outperform wherever they focus,
including in CSR where the company has the most ambitious corporate
responsibility programme in the industry through its Carbon 20 initiative.

Headquartered in the United Kingdom, the company employs about 25,000 people
worldwide, with operations in over 60 countries and sales in almost 200
countries.

For more information visit www.rb.com

Enquiries:

Jo Speed - Investor Relations: [phone]

Andraea Dawson-Shepherd - Media: [phone]

David Litterick/Teresa Bianchi (Brunswick) - Media: [phone]